About Dr. Fogelman

Amy G. Fogelman, MD is Board Certified in Internal Medicine with 16 years of experience seeing patients at Harvard-affiliated practices in the Boston area. She has also held a faculty appointment at Harvard Medical School. Dr. Fogelman has been awarded prizes in clinical excellence and leadership at Massachusetts General Hospital (MGH).

Dr. Fogelman graduated with a BA in Biology from Wesleyan University in Connecticut and MD from Boston University School of Medicine. She completed her Internship and Residency at Beth Israel Deaconess Medical Center in Boston and a Chief Residency in Primary Care at the Veterans Affairs Hospital in West Roxbury. She did a fellowship in Primary Care at MGH in Boston.

In addition to General Internal Medicine, Dr. Fogelman has expertise in primary care opioid policies. She led a multi-disciplinary group to create a first-of-its-kind hospital-wide Primary Care pain policy at MGH. As a consultant, she has reviewed a Major Health System’s clinicians’ opioid prescribing. Dr. Fogelman has served on multiple Opioid Task Forces including most recently as a member of the Norfolk County Sheriff’s Task Force on Juvenile Substance Abuse and Mental Health. She was a designated member of the Special Commission to Study Medication-Assisted Treatment for Opioid Use Disorder in the Commonwealth of Massachusetts. 

Dr. Fogelman is a career-long educator who can communicate with medical students, residents, patients, and jury members about complex medical issues in easy to understand terms. She is the Executive Director of Communications for the COVID-19 Action Coalition, a Physician-Led Advocacy Group. She currently serves in several leadership positions at the Massachusetts Medical Society. She sees patients at Fenway Health in Boston.